Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells

International Journal of Gynecological Cancer

Volumn 16, Issue 2, 2006, Pages 690-697

  Yim, E K ^a   Lee, K H ^a   Kim, C J ^a   Park, J S ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Apoptosis; Cervical carcinoma cells; Cisplatin; Proteome analysis

Indexed keywords

BETA ACTIN; CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; DEATH RECEPTOR; DNA; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MOLECULAR MARKER; MYC PROTEIN; RGS PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER SCREENING; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; HUMAN; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CISPLATIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASM PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UTERINE CERVICAL NEOPLASMS;

EID: 33646054140     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00586.x     Document Type: Article

References (23)

1. Zur hausen H Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer J Natl Cancer Inst 2001 93 252 3
2. Scheffner M Munger K Byrne JC Howley PM The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines Proc Natl Acad Sci U S A 1991 88 5523 7
3. Bonomi P Blessing JA Stehman FB DiSaia PJ Walton L Major FJ Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 1985 3 1079 85
4. Cohen SM Lippard SJ Cisplatin: from DNA damage to cancer chemotherapy Prog Nucleic Acid Res Mol Biol 2001 67 93 130
5. Boike GM Petru E Sevin BU et al Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line Gynecol Oncol 1990 38 315 22
6. Huang H Huang SY Chen TT Chen JC Chiou CL Huang TM Cisplatin restores p53 function and enhances the radiosensitivity in HPV 16 E6 containing SiHa cells J Cell Biochem 2004 91 756 65
7. Huang JC Zamble DB Reardon JT HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease Proc Natl Acad Sci U S A 1994 91 10394 8
8. Fichtinger-Schepman AM Dijt FJ Bedford P Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques IARC Sci Publ 1988 89 321 8
9. Zamble DB Mu D Reardon JT Repair of cisplatin-DNA adducts by the mammalian excision nuclease Biochemistry 1996 35 10004 13
10. Bellon SF Coleman JH Lippard SJ DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum (II) Biochemistry 1991 30 8026 35
11. Wang X Martindale JL Holbrook NJ Requirement for ERK activation in cisplatin-induced apoptosis J Biolumin Chemilumin 2000 275 39435 43
12. Manabe M Mie M Yanagida Y Aizawa M Kobatake E Combined effect of electrical stimulation and cisplatin in HeLa cell death Biotechnol Bioeng 2004 20 661 6
13. Rothe M Xiong J Shu HB Williamson K Goddard A Goeddel DV I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction Proc Natl Acad Sci U S A 1996 93 8241 6
14. Tang G Minemoto Y Dibling B et al Inhibition of JNK activation through NF-kappaB target genes Nature 2001 15 3137
15. Wang CY Mayo MW Korneluk RG Goeddel DV Baldwin AS NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 1998 281 1680 3
16. He QY Chiu JF Proteomics in biomarker discovery and drug development J Cell Biochem 2003 89 868 86
17. Reuse S Maenhaut C Dumont JE Regulation of protooncogenes c-fos and c-myc expressions by protein tyrosine kinase, protein kinase C, and cyclic AMP mitogenic pathways in dog primary thyrocytes: a positive and negative control by cyclic AMP on c-myc expression Exp Cell Res 1990 189 33 40
18. Prochownik EV c-Myc as a therapeutic target in cancer Expert Rev Anticancer Ther 2004 4 289 302
19. Prendiville W Davies P Human papillomavirus and cervical cancer In Walter Prendville Philip Davies eds The health professional's HPV handbook London, UK Taylor and Francis Group 2004
20. Middleton K Peh W Southern S et al Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers J Virol 2003 77 10186 201
21. Keating JT Ince T Crum CP Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis Adv Anat Pathol 2001 8 83 92
22. Oh YH Park CK Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas J Korean Med Sci 2000 15 399 406
23. Huang LW Chao SL Hwang JL Chou YY Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms Gynecol Oncol 2002 85 524 8